Matches in Nanopublications for { ?s ?p "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP692839.RAS2jEoYKLR6JGtq0RnUQ5dIvM5BsdNhw_6m2Vur8HWRI130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692839.RAS2jEoYKLR6JGtq0RnUQ5dIvM5BsdNhw_6m2Vur8HWRI130_provenance.
- NP470153.RAlat3VMMEDcwHNth44t_oN-P_Dr-mUgjb69aiA690b1k130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP470153.RAlat3VMMEDcwHNth44t_oN-P_Dr-mUgjb69aiA690b1k130_provenance.
- NP953242.RADtEbo6bOsrMVbyH1rFQM09cOdRCVNjhO4tAGJz-Zyq8130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953242.RADtEbo6bOsrMVbyH1rFQM09cOdRCVNjhO4tAGJz-Zyq8130_provenance.
- assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP953240.RAnZlxiZXAL1JeqJhjJ1AeyHEryd7bPdpxDqXyUk85CWQ130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP953240.RAnZlxiZXAL1JeqJhjJ1AeyHEryd7bPdpxDqXyUk85CWQ130_provenance.
- NP1364179.RAgRhm50iZgz7JpgrSxNPXeWfGFI9sk6YHA39jNer15xo130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1364179.RAgRhm50iZgz7JpgrSxNPXeWfGFI9sk6YHA39jNer15xo130_provenance.
- NP1364180.RAvGkADTnCsWh4y8NFj97yhZ4DnikEZWBF8aKJ4zu5yVo130_assertion description "[Degenerate PCR primers were designed to amplify all known BLP receptors and yielded products from 19/20 small cell lung carcinoma (SCLC) and 12/13 non-small cell lung carcinoma (NSCLC) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1364180.RAvGkADTnCsWh4y8NFj97yhZ4DnikEZWBF8aKJ4zu5yVo130_provenance.